Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice
Authors:
Open Access
- 25 January 2019
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 83 (2) , 368-378
Abstract
Background: The rapid increase in the number of heart failure (HF) patients in parallel with the increase in the number of older people is receiving attention worldwide. HF not only increases mortality but decreases quality of life, creating medical and social problems. Thus, it is necessary to define molecular mechanisms underlying HF development and progression. HMGB2 is a member of the high-mobility group superfamily characterized as nuclear proteins that bind DNA to stabilize nucleosomes and promote transcription. A recent in vitro study revealed that HMGB2 loss in cardiomyocytes causes hypertrophy and increases HF-associated gene expression. However, it’s in vivo function in the heart has not been assessed. Methods and Results: Western blotting analysis revealed increased HMGB2 expression in heart tissues undergoing pressure overload by transverse aorta constriction (TAC) in mice. Hmgb2 homozygous knockout (Hmgb2−/−) mice showed cardiac dysfunction due to AKT inactivation and decreased sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)2a activity. Compared to wild-type mice, Hmgb2−/− mice had worsened cardiac dysfunction after TAC surgery, predisposing mice to HF development and progression. Conclusions: This study demonstrates that upregulation of cardiac HMGB2 is an adaptive response to cardiac stress, and that loss of this response could accelerate cardiac dysfunction, suggesting that HMGB2 plays a cardioprotective role.Keywords
This publication has 29 references indexed in Scilit:
- Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failureCardiovascular Research, 2013
- Quantitative Analysis of the Chromatin Proteome in Disease Reveals Remodeling Principles and Identifies High Mobility Group Protein B2 as a Regulator of Hypertrophic GrowthMolecular & Cellular Proteomics, 2012
- Lifetime Risks of Cardiovascular DiseaseNew England Journal of Medicine, 2012
- Predictors of Long-Term Adverse Outcomes in Elderly Patients Over 80 Years Hospitalized With Heart Failure - A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) -Circulation Journal, 2011
- HMGB proteins: Interactions with DNA and chromatinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart FailureCirculation Journal, 2008
- Impending Epidemic Future Projection of Heart Failure in Japan to the Year 2055Circulation Journal, 2008
- Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathwayGenes & Development, 2006
- Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed AktJournal of Biological Chemistry, 2003
- Mitotic Misregulation and Human AgingScience, 2000